EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies

Simone Amistadi, Letizia Fontana, Chiara Magnoni iD, Tristan Felix, Matteo Kane Charvin, Pierre Martinucci, Candice Gautier, Lilian Greau, Bettina Bessières, Panagiotis Antoniou, Oriana Romano, Eric Allemand und 2 weitere

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Simone Amistadi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chromatin and Gene Regulation during Development, Imagine Institute, INSERM UMR1163, Paris Cité University, Paris, 75015, France. Hauptthemen laut MEDLINE: Fetal Hemoglobin, Epigenesis, Genetic, beta-Globins, Anemia, Sickle Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency, Agence Nationale de la Recherches, European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beta-hemoglobinopathies are severe genetic diseases caused by mutations affecting the production of the adult β-globin chain. The clinical severity is mitigated by the co-inheritance of mutations that reactivate the production of the fetal β-like γ-globin in adults. However, the epigenetic mechanisms underlying the adult-to-fetal hemoglobin (HbA-to-HbF) switching are still not fully understood. Here, we used epigenome editing technologies to dissect the molecular mechanisms underlying γ- and β-globin gene regulation and to develop novel potential therapeutics for β-hemoglobinopathies. Targeted removal of DNA methylation by dCas9-Tet1 (alone or together with the deposition of histone acetylation by CBP-dCas9) at the fetal promoters led to efficient and durable γ-globin reactivation, demonstrating that DNA methylation is a driver for HbF repression. This strategy, characterized by high specificity and a good safety profile, led to a substantial correction of the pathological phenotype in erythroid cells from patients with sickle cell disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal HemoglobinEpigenesis, Geneticbeta-GlobinsAnemia, Sickle CellHemoglobinopathiesHumansDNA Methylationgamma-GlobinsPromoter Regions, GeneticGene EditingCRISPR-Cas SystemsErythroid Cells

Substanzen

Fetal Hemoglobingamma-Globinsbeta-Globins

Autor:innen und Institutionen

  • Laboratory of Chromatin and Gene Regulation during Development, Imagine Institute, INSERM UMR1163, Paris Cité University, Paris, 75015, France.
  • Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, Imagine Institute, INSERM UMR1163, Paris, 75015, France.
  • Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UAR3633, Paris Cité University, Paris, 75015, France.
  • Service de Médecine Génomique des Maladies Rares, Hôpital Necker-Enfants Malades, Paris, 75015, France.
  • Department of Molecular Medicine, University of Padova, Padova, 35122, Italy.
  • Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, 79098, Freiburg, Germany.

ORCID-Profile: Chiara Magnoni, Claudio Mussolino, Annarita Miccio

Förderung

  • French National Research Agency
  • Agence Nationale de la Recherches
  • European Cooperation in Science and Technology
  • Institut Imagine
  • Fondation pour la Recherche Médicale

Zitieren

APA

Amistadi, S., Fontana, L., Magnoni, C., Felix, T., Charvin, M. K., Martinucci, P., Gautier, C., Greau, L., Bessières, B., Antoniou, P., Romano, O., Allemand, E., Mussolino, C., & Miccio, A. (2025). Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf637

Vancouver

Amistadi S, Fontana L, Magnoni C, Felix T, Charvin MK, Martinucci P, et al. Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf637

BibTeX
@article{Amistadi2025,
  author = {Amistadi, Simone and Fontana, Letizia and Magnoni, Chiara and Felix, Tristan and Charvin, Matteo Kane and Martinucci, Pierre and Gautier, Candice and Greau, Lilian and Bessières, Bettina and Antoniou, Panagiotis and Romano, Oriana and Allemand, Eric and Mussolino, Claudio and Miccio, Annarita},
  title = {Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf637}
}
Kostenlos starten →